4.6 Letter

Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Oncology

Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review

Michele Fiore et al.

Summary: Background and objective: Despite advances in the multidisciplinary management of pancreatic cancer, the prognosis remains poor due to early disease progression. This review provides an update on the current status of pre-treatment evaluation for pancreatic cancer. Methods: An extensive review of relevant articles on traditional imaging, functional imaging, and minimally invasive surgical procedures was conducted. Prospective observational studies, retrospective analyses, and meta-analyses were included. Key content and findings: Each imaging modality has its own advantages and limitations, with reported sensitivity, specificity, and accuracy. The increasing role of neoadjuvant therapy and patient-tailored treatment selection based on tumor staging are discussed. Conclusions: A multimodal pre-treatment workup improves staging accuracy and guides treatment selection for pancreatic cancer patients.

JOURNAL OF GASTROINTESTINAL ONCOLOGY (2023)

Article Oncology

The yield of staging laparoscopy for resectable and borderline resectable pancreatic cancer in the PREOPANC randomized controlled trial

Jelle C. van Dongen et al.

Summary: This study aimed to evaluate the value of staging laparoscopy in detecting occult metastases in patients with resectable or borderline resectable pancreatic cancer. The results showed that staging laparoscopy could detect occult metastases in about 10% of patients, and these patients were more likely to receive palliative systemic chemotherapy.
Article Oncology

Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial

Eva Versteijne et al.

Summary: This study investigates the impact of neoadjuvant chemoradiotherapy on the survival of patients with resectable and borderline resectable pancreatic cancer. The results demonstrate that neoadjuvant chemoradiotherapy improves overall survival compared to upfront surgery in these patients.

JOURNAL OF CLINICAL ONCOLOGY (2022)